SARS-CoV-2 structural proteins affect the expression of IL-8 and TNF-α cytokines and APOBEC genes in human lung A549 and liver Huh-7 cells

1 R. S. Harris and J. P. Dudley, APOBECs and virus restriction, Virology 479–480 (2015) 131–145; https://doi.org/10.1016/j.virol.2015.03.012 Search in Google Scholar

2 N. Lovšin, B. Gangupam and M. Bergant Marušič, The intricate interplay between APOBEC3 proteins and DNA tumour viruses, Pathogens 13(3) (2024) Article ID 187 (19 pages); https://doi.org/10.3390/pathogens13030187 Search in Google Scholar

3 P. Simmonds, Rampant C®U hypermutation in the genomes of SARS-CoV-2 and other corona-viruses: Causes and consequences for their short- and long-term evolutionary trajectories, mSphere 5(3) (2020); https://doi.org/10.1128/mSphere.00408-20 Search in Google Scholar

4 S. M. Wang and C. T. Wang, APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein, Virology 388(1) (2009) 112–120; https://doi.org/10.1016/j.virol.2009.03.010 Search in Google Scholar

5 Y. H. Zheng, N. Lovsin and B. M. Peterlin, Newly identified host factors modulate HIV replication, Immunol. Lett. 97(2) (2005) 225–234; https://doi.org/10.1016/j.imlet.2004.11.026 Search in Google Scholar

6 Y. L. Chiu and W. C. Greene, The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements, Annu. Rev. Immunol. 26 (2008) 317–353; https://doi.org/10.1146/annurev.immunol.26.021607.090350 Search in Google Scholar

7 C. M. Okeoma, N. Lovsin, B. M. Peterlin and S. R. Ross, APOBEC3 inhibits mouse mammary tumour virus replication in vivo, Nature 445(7130) (2007) 927–930; https://doi.org/10.1038/nature05540 Search in Google Scholar

8 Y. H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata and B. M. Peterlin, Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication, J. Virol. 78(11) (2004) 6073–6076; https://doi.org/10.1128/JVI.78.11.6073-6076.2004 Search in Google Scholar

9 B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin and D. Trono, Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts, Nature 424(6944) (2003) 99–103; https://doi.org/10.1038/nature01709 Search in Google Scholar

10 J. Ratcliff and P. Simmonds, Potential APOBEC-mediated RNA editing of the genomes of SARS--CoV-2 and other coronaviruses and its impact on their longer term evolution, Virology 556 (2021) 62–72; https://doi.org/10.1016/j.virol.2020.12.018 Search in Google Scholar

11 N. Lindič, M. Budič, T. Petan, B. A. Knisbacher, E. Y. Levanon and N. Lovšin, Differential inhibition of LINE1 and LINE2 retrotransposition by vertebrate AID/APOBEC proteins, Retrovirology 10 (2013) Article ID 156 (16 pages); https://doi.org/10.1186/1742-4690-10-156 Search in Google Scholar

12 S. Sharma, S. K. Patnaik, R. T. Taggart, E. D. Kannisto, S. M. Enriquez, P. Gollnick and B. E. Baysal, APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages, Nat. Commun. 6 (2015) Article ID 6881 (15 pages); https://doi.org/10.1038/ncomms7881 Search in Google Scholar

13 P. Simmonds and M. A. Ansari, Extensive C®U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA, PLoS Pathog. 17(6) e1009596 (25 pages); https://doi.org/10.1371/journal.ppat.1009596 Search in Google Scholar

14 R. Pecori, S. Di Giorgio, J. Paulo Lorenzo and F. N. Papavasiliou, Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination, Nat. Rev. Genet. 23(8) (2022) 505–518; https://doi.org/10.1038/s41576-022-00459-8 Search in Google Scholar

15 K. Cervantes-Gracia, A. Gramalla-Schmitz, J. Weischedel and R. Chahwan, APOBECs orchestrate genomic and epigenomic editing across health and disease, Trends Genet. 37(11) (2021) 1028–1043; https://doi.org/10.1016/j.tig.2021.07.003 Search in Google Scholar

16 P. V. Markov, M. Ghafari, M. Beer, K. Lythgoe, P. Simmonds, N. I. Stilianakis and A. Katzourakis, The evolution of SARS-CoV-2, Nat. Rev. Microbiol. 21(6) (2023) 361–379; https://doi.org/10.1038/s41579-023-00878-2 Search in Google Scholar

17 K. Kim, P. Calabrese, S. Wang, C. Qin, Y. Rao, P. Feng and X. S. Chen, The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness, Sci Rep. 12(1) (2022) Article ID 14972 (15 pages); https://doi.org/10.1038/s41598-022-19067-x Search in Google Scholar

18 N. J. Hardenbrook and P. Zhang, A structural view of the SARS-CoV-2 virus and its assembly, Curr. Opin. Virol. 52 (2022) 123–134; https://doi.org/10.1016/j.coviro.2021.11.011 Search in Google Scholar

19 S. Khan, M. S. Shafiei, C. Longoria, J. W. Schoggins, R. C. Savani and H. Zaki, SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway, Elife 10 (2021) e68563 (26 pages); https://doi.org/10.7554/eLife.68563 Search in Google Scholar

20 C. B. Forsyth, L. Zhang, A. Bhushan, B. Swanson, L. Zhang, J. I. Mamede, R. M. Voigt, M. Shaikh, P. A. Engen and A. Keshavarzian, The SARS-CoV-2 S1 spike protein promotes MAPK and NF-kB activation in human lung cells and inflammatory cytokine production in human lung and intestinal epithelial cells, Microorganisms 10(10) (2022) Article ID 1996; https://doi.org/10.3390/microorganisms10101996 Search in Google Scholar

21 M. G. Frank, M. Fleshner and S. F. Maier, Exploring the immunogenic properties of SARS-CoV-2 structural proteins: PAMP:TLR signaling in the mediation of the neuroinflammatory and neurologic sequelae of COVID-19, Brain Behav. Immun. 111 (2023) 259–269; https://doi.org/10.1016/j.bbi.2023.04.009 Search in Google Scholar

22 N. Wanner, G. Andrieux, I. M. P. Badia, C. Edler, S. Pfefferle, M. T. Lindenmeyer, C. Schmidt-Lauber, J. Czogalla, M. N. Wong, Y. Okabayashi, F. Braun, M. Lütgehetmann, E. Meister, S. Lu, M. L. M. Noriega, T. Günther, A. Grundhoff, N. Fischer, H. Bräuninger, D. Lindner, D. Westermann, F. Haas, K. Roedl, S. Kluge, M. M. Addo, S. Huber, A. W. Lohse, J. Reiser, B. Ondruschka, J. P. Sperhake, J . Saez-Rodriguez, M. Boerries, S. S. Hayek, M. Aepfelbacher, P. Scaturro, V. G. Puelles and T. B. Huber, Molecular consequences of SARS-CoV-2 liver tropism, Nat. Metab. 4(3) (2022) 310–319; https://doi.org/10.1038/s42255-022-00552-6 Search in Google Scholar

23 N. Lovšin and J. Marc, Glucocorticoid receptor regulates TNFSF11 Transcription by binding to glucocorticoid responsive element in TNFSF11 proximal promoter region, Int. J. Mol. Sci. 22(3) (2021) Article ID 1054 (14 pages); https://doi.org/10.3390/ijms22031054 Search in Google Scholar

24 C. K. Yuen, J. Y. Lam, W. M. Wong, L. F. Mak, X Wang, H. Chu, J.-P. Cai, D.-Y. Jin, K. K.-W. To, J. F.-W. Chan, K.-Y. Yuen and K.-H. Kok, SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists, Emerg. Microbes Infect. 9(1) (2020) 1418–1428; https://doi.org/10.1080/22221751.2020.1780953 Search in Google Scholar

25 C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang and B. Cao, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet 95(10223) (2020) 497–506; https://doi.org/10.1016/s0140-6736(20)30183-5 Search in Google Scholar

26 C. Qin, L. Zhou, Z. Hu, S. Zhang, S. Yang, Y. Tao, C. Xie, K. Ma, K. Shang, W. Wang and D.-S. Tian, Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China, Clin. Infect. Dis. 71(15) (2020) 762–768; https://doi.org/10.1093/cid/ciaa248 Search in Google Scholar

27 H. Yang and Z. Rao, Structural biology of SARS-CoV-2 and implications for therapeutic development, Nat. Rev. Microbiol. 19(11) (2021) 685–700; https://doi.org/10.1038/s41579-021-00630-8 Search in Google Scholar

28 Y. Nakata, H. Ode, M. Kubota, T. Kasahara, K. Matsuoka, A. Sugimoto A, M. Imahashi, Y. Yokomaku and Y. Iwatani, Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome, Nucleic Acids Res. 51(2) (2023) 783–795; https://doi.org/10.1093/nar/gkac1238 Search in Google Scholar

29 P. Jalili, D. Bowen, A. Langenbucher, S. Park, K. Aguirre, R. B. Corcoran, A. G. Fleischman, M. S. Lawrence, L. Zou and R. Buisson, Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots, Nat. Commun. 11(1) (2020) Article ID 2971 (13 pages); https://doi.org/10.1038/s41467-020-16802-8 Search in Google Scholar

30 E. K. Law, R. Levin-Klein, M. C. Jarvis, H. Kim, P. P. Argyris, M. A. Carpenter, G. J. Starrett, N. A. Temiz, L. K. Larson, C. Durfee, M. B. Burns, R. I. Vogel, S. Stavrou, A. N. Aguilera, S. Wagner, D. A. Largaespada, T. K. Starr, S. R. Ross and R. S. Harris, APOBEC3A catalyzes mutation and drives carcinogenesis in vivo, J. Exp. Med. 217(12) (2020) e20200261 (22 pages); https://doi.org/10.1084/jem.20200261 Search in Google Scholar

31 M. B. Burns, L. Lackey, M. A. Carpenter, A. Rathore, A. M. Land, B. Leonard, E. W. Refsland, D. Kotandeniya, N. Tretyakova, J. B. Nikas, D. Yee, N. A. Temiz, D. E. Donohue, R. M. McDougle, W. L. Brown, E. K. Law and R. S. Harris, APOBEC3B is an enzymatic source of mutation in breast cancer, Nature 494(7437) (2013) 366–370; https://doi.org/10.1038/nature11881 Search in Google Scholar

32 J. Liu, Y. Li, Q. Liu, Q. Yao, X. Wang, H. Zhang, R. Chen, L. Ren, J. Min, F. Deng, B. Yan, L. Liu, Z. Hu, M. Wang and Y. Zhou, SARS-CoV-2 cell tropism and multiorgan infection, Cell Discov. 7(1) (2021) Article ID 17 (4 pages); https://doi.org/10.1038/s41421-021-00249-2 Search in Google Scholar